Collecting Tumor Samples From Patients With Gynecological Tumors

Inclusion Criteria: * Any of the following: * Patients who have had gynecologic tissue removed during surgery to diagnosis, treat, monitor, and/or prevent primary, persistent, or recurrent gynecologic cancer of the ovary, peritoneum, fallopian tube, cervix, uterine corpus, vagina, or vulva, meeting at least one of the following criteria: * Group A: Women who underwent surgery, were diagnosed with a primary gynecologic malignancy of the ovary, cervix, uterine corpus, or vulva, and have primary tumor, normal tissue, and blood available for submission for this protocol * Patients with ovarian cancer including all stages, grades, and common epithelial cell types * Invasive cancers and serous and mucinous borderline tumors of low malignant potential are allowed * At least 1 gram of frozen primary tumor tissue must be submitted for this protocol for patients with FIGO stage III or IV epithelial ovarian cancer * Patients with an invasive malignancy of the cervix or uterine corpus including all stages, grades, and common cell types * Patients with squamous cell carcinoma of the vulva * Group B: Women who underwent surgery and were diagnosed with a rare gynecologic malignancy of the ovary, peritoneum, fallopian tube, cervix, uterine corpus, vagina, vulva, a gestational trophoblastic tumor, or a tumor arising in endometriosis, and have tumor tissue available for submission for this protocol * Patients with a rare gynecologic malig…